ストックスクリーナーアプリを入手
15.07
0.74%
0.11
アフターアワーズ：
15.07
前日終値:
$14.96
開ける：
$14.9
24時間の取引高:
609.47K
Relative Volume:
0.83
時価総額：
$5.34B
収益：
$4.79B
当期純損益:
$-317.00M
株価収益率:
-16.56
EPS:
-0.91
ネットキャッシュフロー:
$-59.00M
1週間 パフォーマンス:
-0.07%
1か月 パフォーマンス:
+3.01%
6か月 パフォーマンス:
+3.93%
1年 パフォーマンス:
-21.88%
1日の値動き範囲:
$14.87
$15.29
1週間の範囲:
$14.14
$15.29
52週間の値動き範囲:
$10.45
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
BLCO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.07 | 5.29B | 4.79B | -317.00M | -59.00M | -0.91 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-03-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 開始されました | Raymond James | Outperform |
| 2024-05-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 開始されました | Stifel | Hold |
| 2023-10-03 | 再開されました | Evercore ISI | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 開始されました | Needham | Hold |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-12 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-06-24 | 開始されました | Evercore ISI | Outperform |
| 2022-06-06 | 開始されました | Citigroup | Buy |
| 2022-05-31 | 開始されました | Deutsche Bank | Hold |
| 2022-05-31 | 開始されました | Goldman | Neutral |
| 2022-05-31 | 開始されました | Guggenheim | Buy |
| 2022-05-31 | 開始されました | JP Morgan | Neutral |
| 2022-05-31 | 開始されました | Jefferies | Buy |
| 2022-05-31 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 開始されました | Wells Fargo | Overweight |
| 2022-05-11 | 開始されました | Cowen | Outperform |
すべてを表示
Bausch Lomb Corp (BLCO) 最新ニュース
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13 - BioSpace
Global Eye Health Leader Bausch + Lomb Announces Q3 Earnings Date and Strategic Investor Day Pipeline Review - Stock Titan
Applying Elliott Wave Theory to Bausch + Lomb Corporation2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
Can Bausch + Lomb Corporation (S2L) stock deliver strong annual returnsJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know - Yahoo Finance
Bausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade) - Seeking Alpha
Trade Recap: Why is Bausch Lomb Corporation stock going upJuly 2025 Market Mood & Safe Capital Growth Tips - خودرو بانک
Goldman Sachs Group Inc. Grows Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb Corporation $BLCO Shares Sold by Dynamic Technology Lab Private Ltd - MarketBeat
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Vident Advisory LLC Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Aug Shorts: Is Bausch Lomb Corporation exposed to currency risksEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Clearline Capital LP Acquires 247,149 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Cubist Systematic Strategies LLC Takes $2.12 Million Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO): Valuation Perspective After New Clinical Data and ASANA Lens Launch - Yahoo Finance
Revolutionary Full Range Vision Lens: Bausch + Lomb's enVista Envy Succeeds in 501-Patient Trial - Stock Titan
Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers - Sahm
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers - BioSpace
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why - Yahoo Finance
Little Excitement Around Bausch + Lomb Corporation's (NYSE:BLCO) Revenues - 富途牛牛
Bausch + Lomb Corporation - Baystreet.ca
Complete Custom Contact Lens Portfolio: Bausch + Lomb Launches ASANA for Complex Vision Conditions - Stock Titan
Is Bausch + Lomb Corporation being accumulated by smart money2025 Big Picture & Fast Momentum Entry Tips - خودرو بانک
Can trapped investors hope for a rebound in Bausch + Lomb CorporationTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Is Bausch + Lomb Corporation exposed to currency risksJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed - GlobeNewswire Inc.
Is Bausch + Lomb Corporation stock reversal real or fakeWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Is Bausch + Lomb Corporation backed by strong institutional buyingBond Market & Daily Entry Point Alerts - خودرو بانک
Will Bausch + Lomb Corporation continue its uptrend2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Tools to assess Bausch + Lomb Corporation’s risk profileJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Is Bausch + Lomb Corporation stock a falling knife or bargain buyEarnings Recap Report & Safe Entry Point Alerts - khodrobank.com
Sector ETF performance correlation with Bausch + Lomb CorporationWeekly Investment Report & Community Verified Swing Trade Signals - Newser
Is Bausch + Lomb Corporation stock bottoming outJuly 2025 Technicals & Fast Moving Stock Watchlists - Newser
Visualizing Bausch + Lomb Corporation stock with heatmapsTrade Performance Summary & AI Optimized Trade Strategies - Newser
Can volume confirm reversal in Bausch + Lomb CorporationEarnings Risk Report & High Return Stock Watch Alerts - Newser
What to expect from Bausch + Lomb Corporation in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
Analyzing Bausch + Lomb Corporation with multi timeframe chartsTake Profit & Risk Controlled Stock Pick Alerts - Newser
Technical signs of recovery in Bausch + Lomb CorporationForecast Cut & Weekly Consistent Profit Watchlists - Newser
Tools to monitor Bausch + Lomb Corporation recovery probabilityVolume Spike & AI Driven Price Forecasts - Newser
Using Bollinger Bands to evaluate Bausch + Lomb CorporationEarnings Recap Summary & AI Enhanced Trading Alerts - Newser
Bausch Lomb Corp (BLCO) 財務データ
収益
当期純利益
現金流量
EPS
0.91%
1.74%
大文字化:
|
ボリューム (24 時間):